首页> 外文期刊>Antioxidants and redox signalling >A protein disulfide isomerase/thioredoxin-1 complex is physically attached to exofacial membrane tumor necrosis factor receptors: Overexpression in chronic lymphocytic leukemia cells
【24h】

A protein disulfide isomerase/thioredoxin-1 complex is physically attached to exofacial membrane tumor necrosis factor receptors: Overexpression in chronic lymphocytic leukemia cells

机译:蛋白质二硫键异构酶/硫氧还蛋白-1复合物物理连接到颜面膜肿瘤坏死因子受体:在慢性淋巴细胞性白血病细胞中过表达

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Aims: The 3D structures and functions of cysteine-rich receptors such as tumor necrosis factor receptors (TNFRs) are redox-modulated by dithiol-disulfide exchange. TNFR superfamily members participate in growth regulation in B-cell chronic lymphocytic leukemia (CLL), and tissue stromal cells interact with leukemia cells, profoundly affecting their viability via release of redox-active components, including cysteine, thioredoxin-1 (Trx1), and Trx reductase. Trx1 was previously shown to enhance release of TNF, which acts as an autocrine/paracrine growth factor in CLL. The nature of the mechanism is not known, however. Here, we investigated whether Trx1 and protein disulfide isomerase (PDI), a chaperone and Trx-family member, may interact with TNFRs. Results: We found direct physical association between PDI and TNFR1 or TNFR2 by coclustering and affinity isolation. PDI (57kDa) formed covalent/reduction- sensitive 69-kDa complexes with Trx1 (12kDa) in a majority of CLL cell samples, detected at low levels only in control B-cells. Functionally, the TNF/TNFR signaling via the nuclear factor kappa B-driven autocrine loop was disrupted in a dose-dependent fashion by PDI-inhibitors bacitracin, anti-PDI, or anti-Trx1 antibodies, resulting in reduced viability. PDI was significantly overexpressed in immunoglobulin heavy-chain variable (IGHV) unmutated versus mutated CLL (p=0.0102), and amplified TNF release was observed in the former group. Innovation: This study points out a previously unrecognized physical and functional association of TNFRs with the redox-active proteins PDI and Trx1. Conclusion: We describe here a new level of TNF regulation, in which membrane TNFRs are redox controlled at the exofacial surface by PDI/Trx1. These findings shed new light on the observed survival benefit in CLL B-cells exerted by TNFR-superfamily ligands and point at potential therapeutic strategies.
机译:目的:富含半胱氨酸的受体(例如肿瘤坏死因子受体(TNFR))的3D结构和功能通过二硫醇-二硫键交换进行氧化还原调节。 TNFR超家族成员参与B细胞慢性淋巴细胞性白血病(CLL)的生长调节,并且组织基质细胞与白血病细胞相互作用,通过释放氧化还原活性成分(包括半胱氨酸,硫氧还蛋白1(Trx1)和Trx还原酶。 Trx1先前显示可增强TNF的释放,而TNF是CLL中的自分泌/旁分泌生长因子。但是,该机制的性质未知。在这里,我们调查了Trx1和蛋白二硫键异构酶(PDI),分子伴侣和Trx家族成员是否可能与TNFR相互作用。结果:我们通过共聚和亲和分离发现了PDI与TNFR1或TNFR2之间的直接物理联系。在大多数CLL细胞样品中,PDI(57kDa)与Trx1(12kDa)形成了共价/还原敏感的69-kDa复合物,仅在对照B细胞中低水平检测到。在功能上,经由核因子κB驱动的自分泌环的TNF / TNFR信号以剂量依赖的方式被PDI抑制剂杆菌肽,抗PDI或抗Trx1抗体破坏,导致生存能力降低。 PDI在未突变的免疫球蛋白重链变量(IGHV)与突变的CLL中显着过表达(p = 0.0102),在前一组中观察到TNF释放增强。创新:这项研究指出了TNFRs与氧化还原活性蛋白PDI和Trx1之间以前未被认识的物理和功能联系。结论:我们在这里描述了新的TNF调节水平,其中膜TNFR通过PDI / Trx1在面膜表面被氧化还原控制。这些发现为由TNFR超家族配体在CLL B细胞中观察到的生存获益提供了新的启示,并指出了潜在的治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号